Cargando…

Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier

HIV-1 can cross the blood-brain barrier (BBB) to penetrate the brain and infect target cells, causing neurocognitive disorders as a result of neuroinflammation and brain damage. Here, we examined whether antibodies targeting the HIV-1 envelope glycoproteins interfere with the transcytosis of virions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorin, Valérie, Danckaert, Anne, Porrot, Françoise, Schwartz, Olivier, Afonso, Philippe V., Mouquet, Hugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Observation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587443/ https://www.ncbi.nlm.nih.gov/pubmed/33082263 http://dx.doi.org/10.1128/mBio.02424-20

Ejemplares similares

Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission
por: Malbec, Marine, et al.
Publicado: (2013)

Elimination of HIV-1-infected cells by broadly neutralizing antibodies
por: Bruel, Timothée, et al.
Publicado: (2016)

Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells
por: Dufloo, Jérémy, et al.
Publicado: (2022)

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity
por: Prigent, Julie, et al.
Publicado: (2018)

Bystander CD4 T-cell death is inhibited by broadly neutralizing anti-HIV antibodies only at levels blocking cell-to-cell viral transmission
por: Luo, Xiaoyu, et al.
Publicado: (2021)

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
por: Boutin, Marianne, et al.
Publicado: (2022)

Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71
por: Zhu, Ling, et al.
Publicado: (2018)

Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies
por: Gallichotte, Emily N., et al.
Publicado: (2019)

Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants
por: Ibarrondo, F. Javier, et al.
Publicado: (2021)

Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy
por: Hoffmann, Markus, et al.
Publicado: (2022)

Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization Breadth
por: Deshpande, Suprit, et al.
Publicado: (2023)

Broadly neutralizing antibodies potently inhibit cell-to-cell transmission of semen leukocyte-derived SHIV162P3
por: Suphaphiphat, Karunasinee, et al.
Publicado: (2020)

B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies
por: Zhou, Hao, et al.
Publicado: (2021)

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens
por: Counoupas, Claudio, et al.
Publicado: (2022)

Mucosal application of the broadly neutralizing antibody 10-1074 protects macaques from cell-associated SHIV vaginal exposure
por: Suphaphiphat, Karunasinee, et al.
Publicado: (2023)

Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
por: Planas, Delphine, et al.
Publicado: (2022)

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
por: Planas, Delphine, et al.
Publicado: (2023)

Scarcity of autoreactive human blood IgA(+) memory B cells
por: Prigent, Julie, et al.
Publicado: (2016)

Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
por: Lorin, Valérie, et al.
Publicado: (2022)

Evaluation of Dried Blood Spots and Oral Fluids as Alternatives to Serum for Human Papillomavirus Antibody Surveillance
por: Louie, Karly S., et al.
Publicado: (2018)

Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers
por: Molinos-Albert, Luis M., et al.
Publicado: (2022)

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
por: Dufloo, Jérémy, et al.
Publicado: (2018)

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies
por: Bruel, Timothée, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H
por: Zeng, Cong, et al.
Publicado: (2021)

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
por: Zou, Jing, et al.
Publicado: (2022)

Human anti–HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness
por: Pietzsch, John, et al.
Publicado: (2010)

Blood-brain barrier and retroviral infections
por: Miller, Florence, et al.
Publicado: (2012)

Reduced Independence in Daily Living Is Associated with the Gut Microbiome in People with HIV and HCV
por: Taylor, Bryn C., et al.
Publicado: (2020)

HIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer
por: Malbec, Marine, et al.
Publicado: (2013)

Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers
por: Hehle, Verena, et al.
Publicado: (2020)

Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
por: Hubert, Mathieu, et al.
Publicado: (2023)

HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells
por: Chauveau, Lise, et al.
Publicado: (2015)

Single Amino Acid Substitution in the Receptor Binding Domain of Spike Protein Is Sufficient To Convert the Neutralization Profile between Ethiopian and Middle Eastern Isolates of Middle East Respiratory Coronavirus
por: Sugimoto, Satoko, et al.
Publicado: (2023)

Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic Assay
por: Toyoda, Mako, et al.
Publicado: (2023)

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
por: Saunders, Nell, et al.
Publicado: (2022)

IFITM Proteins Incorporated into HIV-1 Virions Impair Viral Fusion and Spread
por: Compton, Alex A., et al.
Publicado: (2014)

Hyperthermia Stimulates HIV-1 Replication
por: Roesch, Ferdinand, et al.
Publicado: (2012)

HIV-1 Is a Poor Inducer of Innate Immune Responses
por: Cingöz, Oya, et al.
Publicado: (2019)

Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai
por: Lau, Susanna K. P., et al.
Publicado: (2020)

COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions
por: Adeniji, Opeyemi S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ifhn2p5iunk99c2a3qja9e01dn